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Objective: To design and preliminarily test a ques-
tionnaire intended to measure patient treatment 
burden resulting from participation in cognitive as-
sessments and interventions.
Methods: An expert consensus process was used to 
develop the concept of patient treatment burden and 
to determine the first set of questionnaire items and 
administration protocol. The pilot questionnaire was 
administered to 20 patients with mild to severe ac-
quired brain injuries on completion of a 2-h or long-
er neuropsychological assessment. Following preli-
minary testing, the questionnaire was revised and 
re-evaluated by a second expert panel and content 
validity was assessed.
Results: Burden was defined as psychologically 
and/or physically aversive symptoms in response 
to cognitive assessment or intervention. The first 
questionnaire contained 21 items assigned to 3 ca-
tegories: physical, cognitive, and emotional. Eighty-
five percent of patients endorsed symptom level in-
creases, with “tired/fatigued” the most frequently 
endorsed item (80% of patients). Instructions and 
test items were easily understood, and the ques-
tionnaire was quick to administer. Content validity 
ratio (CVR) of the revised questionnaire yielded 23 
acceptable items and a subset met the highest CVR 
threshold (>0.78).
Conclusion: This patient-reported outcome will ul-
timately help patients give voice to aversive ex-
periences, and help clinicians and researchers to 
monitor and adapt assessments/treatments appro-
priately. Future steps in development are described. 
Key words: acquired brain injury; neuropsychology; cogni-
tive assessment; neurorehabilitation; patient-reported out-
come; patient burden; questionnaire.
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Patient treatment burden has been described as the “work” involved in being a patient (1). This 
concept includes the investment of time, the mental 
and physical effort allocated to activities, such as drug 
management and self-monitoring, and the impact of the 
above on a patient’s quality of life and functioning (2). 
The physically and/or psychologically aversive 
symptoms that are the immediate result of cognitive 
assessments and interventions constitute what may 
be considered a sub-type of patient treatment burden. 
Such symptoms include headache, fatigue and irrita-
bility. While a number of tools assessing treatment 
burden have been developed (see Eton et al. (2), for 
systematic review), to date, there is a gap in the lite-
rature for tools that measure the aversive effects of 
cognitive assessments and interventions. 
Such a patient-reported outcome (PRO) could al-
low for patients undergoing such procedures to give 
voice to aversive experiences, and for clinicians and 
researchers to monitor whether a cognitive assess-
ment/intervention should be modified on the basis 
of patient experience. This is especially important as 
some neurorehabilitation interventions are intended to 
MAIN MESSAGE
There are currently no tools for measuring adverse ef-
fects (e.g., fatigue, stress) of cognitive testing and inter-
ventions in patients with acquired brain injury (ABI). We 
designed a preliminary questionnaire for patients with 
ABI for measuring adverse effects of cognitive testing 
and interventions, and administered it to 20 patients 
who had completed intensive cognitive assessments. 
The questionnaire asked patients about negative cogniti-
ve, physical and emotional symptoms resulting from the 
session. Eighty-five percent of patients reported worse-
ning of at least one symptom, with feelings of tiredness/
fatigue most common. The questionnaire was then revi-
sed, and experts were asked to rate the appropriateness 
of items.  The questionnaire’s development is ongoing. 
Such a questionnaire is needed to enable patients to 
voice any aversive experiences of cognitive testing/in-
tervention, and to enable clinicians and researchers to 
monitor and adapt assessments and treatments appro-
priately. The tool is particularly relevant for remote (e.g. 
internet-based) assessment and intervention delivery. 
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elicit maximal mental exertion. For example, cognitive 
environmental enrichment paradigms confer neural 
and behavioural benefits in part through continuous 
challenge and time-intensive training (3, 4); moreover, 
there is increasing evidence that too much cognitive 
exertion may have deleterious effects in certain con-
texts (e.g. acute concussion (5–7)).
Such a PRO would support a range of research into 
the impact of aversive experiences. For example, do 
aversive experiences in one therapy result in less enga-
gement in subsequent therapies and, if so, does this oc-
cur at a certain threshold or intensity of burden? Does 
aversive experience impact feasibility and efficacy of 
an intervention and, if so, how? Are aversive effects 
of intensive cognitive activity in acute concussion as-
sociated with poorer recovery?
There are several contexts in which this type of PRO 
would be of particular value. This includes the context 
of remote assessment and treatment (i.e. telephone/
internet-delivered), which may preclude direct patient 
observation, and face-to-face group settings, in which 
social pressures may preclude the open acknowledge-
ment of aversive symptoms. 
Thus, a tool that quickly and easily measures 
symptoms of patient burden attributable to cognitive 
assessment/intervention could provide the therapist/
experimenter with pertinent clinical information, 
permitting timely and appropriate management. Such 
a tool could also foster a greater understanding of the 
potential benefits and harms of cognitive assessments 
and interventions, particularly highly demanding ones, 
helping us to ascertain “how much is too much?” for 
a given patient or population.
As a step towards gaining a better understanding of 
the concept of patient treatment burden in the above-
described contexts, and of documenting its presence, 
we have taken an expert consensus-driven and empi-
rical approach to the initial stages of development of 
a measure of patient treatment burden called the How 
Much is Too Much? questionnaire. The questionnaire 
was specifically designed for patients with acquired 
brain injury (ABI), although it has potential application 
to any cognitively impaired population. 
The primary aims of this paper are: (i) to briefly 
describe the expert consensus process used in the 
development of the construct and first questionnaire 
items; (ii) to describe pilot testing of the tool and 
report rate of item endorsement in patients with ABI; 
and, (iii) to describe item selection agreement between 
expert raters of a revised questionnaire using the con-
tent validity ratio (CVR) item statistic, a measure of 
content validity. 
MATERIAL AND METHODS
Expert consensus process for item selection and tool format
Procedures. The expert consensus process was concerned with: 
(i) establishing the need and purpose for the questionnaire; (ii) 
refining the psychological construct of patient treatment burden 
in the context of cognitive assessment/intervention; and (iii) ge-
nerating items, instructions, and format for the first version of the 
questionnaire (see Box 1). To achieve these aims, a panel of 12 
experts convened: 3 front-line clinicians, 6 clinician-scientists, 
and 3 post-doctoral fellows from disciplines that undertake 
cognitive assessment/intervention in patients with ABI, inclu-
ding concussion, moderate-severe traumatic brain injury (TBI) 
and stroke. Disciplines included neuropsychology (3), clinical 
psychology (4), psychometry (2), occupational therapy (2) and 
rehabilitation therapy (1); the panel also contained expertise in 
methodology and test development. One of the panel members 
had also previously sustained a severe TBI. The current study 
sought to convene a panel with relevant content knowledge from 
their clinical training as well as extensive front-line clinical 
experience with ABI patients and their caregivers. 
Generation of the initial item set entailed the generation of 
an exhaustive list of items by a sub-group of the expert panel. 
An iterative process was used to identify redundancy as well 
as items that might be ambiguous for patients. Each item was 
evaluated by the original panel of 12 experts, during which 
suggestions for adding/removing items, as well as tool format 
and instructions, were given. 
Pilot testing of questionnaire
Participants. The study received approval from the Toronto 
Rehabilitation Institute Research Ethics Board (Jan 2015, 
REB#14-8156-DE). The first version of the tool was adminis-
tered by psychometrists (n = 2) and clinical neuropsychology 
trainees (n = 5) trained in clinical assessment, including the 
administration of questionnaires, and with extensive experience 
with brain-injured patients. These clinicians were also members 
of the expert consensus panel.
Patient participants were a convenience sample. All were 
undergoing clinical neuropsychological assessments for mild 
to severe ABI, either as part of an ongoing clinical research 
study or as part of a clinical assessment on an out-patient ABI 
programme. Inclusion criteria were: history of ABI; aged 18 
years or older; sufficient complaints of cognitive dysfunction 
to warrant neuropsychological assessment; able to provide fully 
informed consent; functional command of English. Participants 
with active psychotic disorder were excluded. Patients with 
moderate-severe TBI or stroke were previous in-patients or 
day hospital patients of the Acquired Brain Injury Program of 
Toronto Rehab. Patients with persisting symptoms of concus-
sion (or post-concussion syndrome; PCS) were recruited from 
Box 1. The “How Much is Too Much?” Questionnaire
Intended purpose: Patient-reported outcome measure to describe 
and quantify increases in aversive cognitive, emotional, and/or physical 
symptoms following cognitive assessments and interventions.
Patient population: Mild to severe acquired brain injury (e.g. stroke, 
mild-severe traumatic brain injury, persisting symptoms of concussion).
Concept: Patients treatment burden is defined as the symptoms 
experienced by the patient as physically or psychologically aversive. 
Symptoms may be cognitive, physical or emotional. 
Administration: Face-to-face or remote (internet-based) delivery. 
www.medicaljournals.se/jrm
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521Measuring patient burden
beyond the first half of raters, the greater the degree of that 
item’s content validity. 
For CVR value interpretation, general principles described 
in Lawshe’s original paper (8) were used, as informed by sug-
gestions by Polit et al. (11), with additional reference to updated 
critical values recalculated by Ayre & Scally (12). CVR cut-offs 
had been previously recalculated in Wilson et al. (9), but were 
not used, due to limitations described by Ayre & Scally (12).
RESULTS
Expert consensus panel for item selection and tool 
format
The need for the tool was unanimously agreed upon 
by panel members, given the clinical importance of a 
patient-centred expression of burden, the need to better 
understand the impact(s) of burden, as described above, 
and the dearth of existing instruments. Broad definitions 
of burden were produced, and the purpose of the tool 
initially conflated measuring patient treatment burden 
with measuring its impact. In smaller follow-up mee-
tings, the working definition was refined and simplified 
to “symptoms experienced by the patient as physically 
or psychologically aversive in response to cognitive 
assessment or intervention” and we established that the 
tool would be designed as a “yardstick” for burden, one 
that could be used to quantify patient treatment burden, 
but did not directly measure the impact of burden itself. 
More concretely, we differentiated between measuring 
the presence and severity of symptoms that a patient 
experiences in response to assessment/intervention vs. 
the consequences or impact of those symptoms. The lat-
ter might include adherence to the training protocol for 
which the burden was measured, the effect of symptoms 
on ability/willingness to participate in a subsequent 
activity or deleterious effects on the brain (e.g. during 
the early post-concussion period).
Before and during the initial meeting, a set of 39 
items was generated by members of the panel. These 
were intended to represent as wide a range as possible 
of aversive symptoms that might be experienced by 
patients in response to cognitive assessment/intervention 
and thereby to represent different components of burden. 
The iterative process yielded a final set of 21 items 
that were included in the first version of the tool. The 
items were categorized provisionally as physical, emo-
tional, cognitive or other. These initial categories were 
based on subjective groupings rather than hypothesized 
psychometric construct dimensions. The purpose of 
this initial grouping was to allow for the generation of 
hypotheses for future iterations of the questionnaire, 
and thus degree of representativeness of the items of 
the categories was not ascertained. 
A consensus was reached with agreement from 
all panel members regarding the format of the ques-
a workshop designed for patients with persisting symptoms of 
concussion. There was no independent medical verification of 
the initial concussion or persisting symptoms.
Clinician evaluation form. This form comprised a series of ques-
tions to enable clinicians administering the questionnaire to: (i) 
provide feedback on the scale and its administration that would be 
used to evaluate the feasibility of the questionnaire and its current 
application; and (ii) to collect basic demographic data on patients. 
Procedures. The purpose of the pilot testing was to ascertain 
which questionnaire items were most frequently and infre-
quently endorsed, and to what degree, in order to inform further 
refinement of items in the scale. For those items with an endor-
sement, we were also interested in whether items would show 
any preliminary evidence of clustering.
Patient participants were recruited by the above-mentioned 
clinicians and all patients provided informed consent. The 
cognitive sessions selected for initial piloting of the tool were 
clinical neuropsychological assessments because of the known 
cognitive demands of these assessments, which are designed to 
test the limits of capacity across multiple cognitive domains.
Assessments ranged from 2 to 5 h and comprised conventional 
clinical neuropsychological measures of attention, concentration, 
and speed of processing, memory function, visuospatial and lang-
uage skills, executive functions, and estimated pre-morbid IQ. 
The first version of the questionnaire was administered at the end 
of the neuropsychological assessment session. After the patient 
left, the clinician then completed the clinician evaluation form.
Content validity ratio of scale items
Procedures. Based on the initial pilot testing, a sub-set of the 
expert panel re-convened to refine the constructs from the original 
scale, and then Lawshe’s (8) CVR was used to establish the base-
line content validity of test items. The CVR is an internationally 
recognized item-statistic used for establishing content validity 
(9). It involves a linear transformation of the proportional level 
of agreement on item level ratings between expert panellists. The 
analysis and data collection was informed by Gilbert & Prion (10).
Ratings were collected from an expert panel (comprising 
members that overlapped with the original consensus panel) 
by asking: “Please rate each item for its appropriateness for 
measuring burden, rating each item as, (2) Essential, (1) Useful, 
but not essential, or (0) Not Necessary or redundant, where 
“Burden” referred to “any elevation in aversive psychological 
or physical/somatic symptoms (e.g. headache, fatigue, irrita-
bility) that you think a brain-injured patient might experience 
following a cognitive assessment/intervention, whether therapist 
delivered (face-to-face or online) or self-administered (e.g. a 
computerized brain exercise).” 
The clinicians in this panel had expert and front-line ex-
perience in treating patients with brain injuries. The experts 
comprised: 4 neuropsychologists, a psychologist in post-
doctoral training in neuropsychology, a doctoral student intern 
in neuropsychology, 2 occupational therapists, 2 social workers, 
2 rehabilitation therapists, and 2 speech-language pathologists. 
One of the clinicians had previously sustained a moderate-severe 
TBI. Years of experience ranged from 5 to 21 years. Their ratings 
were coded and anonymized before analysis. 
CVR values were calculated using Lawshe’s (8) original 
formula: 
CVR = (ne – N/2) / (N/2)
where ne is the number of panellists rating an item as “Es-
sential” and N is the total number of panellists. In other words, 
the more panellists that agreed with an item being “Essential”, 
J Rehabil Med 50, 2018
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tionnaire as well as the delivery protocol, including 
instructions, and these recommendations were used to 
construct the How Much is Too Much? questionnaire, 
version 1. This first version of the questionnaire inclu-
ded 21 items from 3 broad categories. There were 7 
“physical” items, including: tired/fatigued; eye-strain/
blurred vision; headache; pain (other) e.g. neck, arm, 
hand; ear ringing/popping; off balance (physically); 
dizzy/lightheaded. There were 10 “emotional” items: 
overwhelmed; frustrated; upset; stressed; racing 
thoughts; irritable; anxious; embarrassed; lonely/iso-
lated; and sad. There were 2 “cognitive” items: foggy 
and distractible, and 2 additional items that did not 
fall into these categories: uncomfortable and bored. 
The response scale was a 4-point Likert-type scale, 
with the labels: “less”, “same”, “more”, and “much 
more” for patients to rate their current (post-session) 
symptoms with respect to pre-session symptoms. 
Conceptually, higher summed total scores across the 
4-item categories and within each category should 
represent higher levels of burden. The instructions 
for the questionnaire were: “Please rate the extent 
to which you are experiencing any of the following. 
Please simply compare yourself to how you felt before 
starting the session”.
Pilot testing of questionnaire
Two patients did not meet study inclusion criteria of 
ABI (P10 and 17) and were therefore excluded from 
further analyses. Twenty patients with ABI participated 
in the study, 60% of which had PCS. All patients but 
one spoke English as a first language and their Eng-
lish language capacity was described as “fluent”. One 
patient spoke English as a second language (P9) and 
his/her language skill was described as semi-fluent. 
See Table I for patient characteristics.
Item endorsements. Eighty-five percent of patients 
endorsed an increase of at least one symptom. Fig. 1 
shows the number of patients endorsing changes in bur-
den increase on the scale (i.e. endorsements of “more” 
or “much more”). For those items endorsed, physical 
items predominated; 80% of patients endorsed “tired/
fatigued”, 30% endorsed “eye-strain/blurred vision” 
and “headache”, while 25% endorsed “pain (other)” 
and “dizzy/lightheaded”. Regarding emotional items, 
30% of patients endorsed “overwhelmed”, and 35% 
endorsed “stressed”; none endorsed “sad”. For cogni-
tive items, 25% of patients endorsed “distractible” and 
45% endorsed “foggy”.
Table I. Patient characteristics
Diagnosis
n (% of 
sample)
Sex
n (%) 
male
Age, years
Mean 
(range)
Persisting symptoms of concussion/
post-concussion syndrome
12 (60) 8 (67) 38.2
Moderate-severe TBI 6 (30) 6 (100) 37.0
Stroke 2 (10) 2 (100) 45.0
Total 20 16 (80) 38.5 (20–58)
TBI: traumatic brain injury.
Fig. 1. Number of patients endorsing each of the 21 questionnaire items (maximum count of 20 patients per 
item). Counts of patients rating each item as either “more” (experiencing pre–post session increases in magnitude 
of a given symptom) or “much more” (experiencing greater pre–post session increases in magnitude of a given 
symptom), are shown.
www.medicaljournals.se/jrm
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Patterns of endorsements. Next, item endorsements 
within each patient were examined. The largest num-
ber of symptoms endorsed by a patient as “more” or 
“much more” were 13 and 14 (out of 21), by 2 pa-
tients. Patient 5 showed an increase in 14 symptoms 
and patient 9 showed an increase in 13 symptoms. 
Three patients showed no endorsements. Many of the 
items, even with this vulnerable population and under 
a challenging assessment, showed no endorsements, 
and 30% of patients showed a reduction of at least 
one aversive symptom. Fig. 2 shows the number of 
symptoms endorsed and not endorsed by each patient. 
Overall, 85% (17 of the 20 eligible patients) showed 
endorsement of at least one symptom increase (i.e. 
“more” or “much more”). 
As an exploratory analysis, we examined whether 
specific items were more frequently endorsed by pa-
tients who made a greater (5 or more items) vs. fewer 
(4 or fewer items) total number of item endorsements. 
For those with fewer overall endorsements, more 
physical symptoms were endorsed than non-physical, 
even though there are a greater number of non-physical 
items. Specifically, 5 of the 8 patients who endorsed 4 
or fewer items showed this pattern, and these patients 
reported pre–post session increases in tiredness/fati-
gue, eye-strain/blurred vision, or headaches. In these 
patients, tiredness/fatigue co-occurred with either eye-
strain/blurred vision or with headaches. Interestingly, 
all 3 of the patients who endorsed only 1 symptom 
endorsed “tired/fatigued”, and all but 1 of the 8 patients 
endorsed “tired/fatigued”. For those patients showing 
a greater overall number of endorsements (i.e. 5 or 
more items), 5 of 9 endorsed more 
non-physical than physical symp-
toms, with frequently endorsed 
items including: “foggy, stressed, 
and overwhelmed”, which tended 
to cluster together. Regarding 
physical symptoms, all 9 patients 
reported increases in “tiredness/
fatigue”, and frequently reported 
“eye-strain/blurred vision, hea-
daches, pain (other), and feeling 
dizzy/lightheaded”, which tended 
to cluster together.
Preliminary feasibility: clinician 
evaluation form. The mean admi-
nistration time for the questionnaire 
was 1 min 42.1 s (range 30 s to 6 
min). There were no difficulties 
reported in understanding the tool, 
with the exception of 3 patients: 
the patient with English as second 
language for whom some items 
needed to be defined (e.g. “overwhelmed”), 1 patient 
who requested clarification on how to indicate absence 
of a symptom before and after the cognitive testing 
session, and 1 patient who requested clarification 
regarding whether to report changes relative to the 
start of the current testing session or to the post-injury 
period. All clinicians indicated that the reading level 
of the questionnaire was appropriate for their patients. 
Clinician feedback for improving the questionnaire 
included: (i) differentiating items as relating to effects 
of the cognitive testing session vs. effects of patient-
clinician rapport (e.g. embarrassed); (ii) modifying the 
instructions to read “Please simply compare yourself 
to how you felt before starting today’s session”; and 
(iii) expanding the response scale to include “symptom 
not experienced pre- or post-assessment”.
Content validity ratio of scale items
The sub-set of the expert panel that re-convened to 
refine the constructs from the original scale expanded 
the initial items to include the items listed in Fig. 3. 
For example, as 80% of patients endorsed the item 
“tired/fatigued”, we sought to refine this construct 
by adding a number of items that examined cognitive 
vs. physical fatigue (e.g. “mentally sluggish/slowed 
down” vs. “sleepy/drowsy”). No items were excluded 
at this stage. 
Fig. 3 illustrates that more than half of the items 
(23/40) were rated as “essential” by more than 50% 
of the raters. Four of the items were rated as “useless 
or redundant” by at least half of the raters. 
Fig. 2. Counts of symptoms rated in each of 2 categories, for each patient. For the “Less or same” 
category, patients indicated either no change or pre–post session decreases in magnitude of a 
given symptom; For the “More or much more” category, patients indicated experiencing pre–post 
session increases in magnitude of a given symptom or greater pre–post session increases in 
magnitude of a given symptom. Maximum count of 21 items per patient.
J Rehabil Med 50, 2018
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was also used to evaluate the items. For items with 14 
raters, the CVRCritical = 0.571. For those items missing 
1 rater, the adjusted cut-off was CVRCritical = 0.538. 
Using these values, the following items continued to 
meet the cut-off for item appropriateness (i.e. “frustra-
ted”, “headache”, “mentally sluggish/slowed down”, 
“overwhelmed”, “pain (other): e.g. neck, arm, hand”, 
“sad”, “tired/fatigued”, and “trouble staying focused/
concentrating”). 
DISCUSSION
Cognitive assessments and interventions are widely 
used in the ABI population, but a tool to measure their 
potentially burdensome impact on patients has yet to 
be developed. We developed a pilot questionnaire to do 
so. We found that a large majority of our patients with 
The CVR values are summarized in Table II, and 
provide an indication of the degree of agreement 
between members of the consensus panel regarding 
appropriateness or inappropriateness of the item. Ac-
cording to Lawshe (8), CVR values greater than 0 give 
some assurance of content validity. Twenty-one items 
met this recommendation. Using a higher standard of 
0.78 or more has been recommended by Polit et al. (11) 
for panels with 3 or more raters. Five of the items met 
this criterion with high “essential” agreement (“tired/
fatigued”; “trouble staying focused/concentrating”; 
“frustrated”; “headache”; “overwhelmed”). A number 
of further items approached the criterion. Using Ayre 
& Scally’s (12) re-calculated critical CVR values 
using exact binomial probabilities assures a level of 
agreement beyond that of chance (α = 0.05) matched to 
the number of panellists contributing to each item. This 
Fig. 3. Panellist endorsement of all items in revised questionnaire, listed in alphabetical order.
	
0	 2	 4	 6	 8	 10	 12	 14	 16	
Worn	Out	
Upset/	Angry	
Upset	
Uncomfortable	
Trouble	staying	focused/	concentrating	
Tired/	Fatigued	
Tense	
Stressed	
Stiff	shoulders	
Sore	eyes	
Sleepy/	Drowsy	
Sad	
Racing	thoughts	
Pain/	weakness	(other)	
Pain	(other):	e.g.,	neck,	arm,	hand	
Overwhelmed	
Off-balance	
No	Energy	
Muscle	aches	
Mentally	sluggish/	slowed	down	
Lonely/	Isolated	
Irritable	
Headache	
Head	feels	heavy	
Frustrated	
Foggy	
Eye	strain	or	blurred	vision	
Embarassed	
Ear	ringing/	popping	
Dizzy/	Lightheaded	
Distressed	
Distractible	
Discouraged	
Desire	to	lay	down	
Desire	to	close	eyes	
Confused	
Can't	think	clearly	
Bored	
Arms/	legs	feel	weak		
Anxious	
Number	of	endorsements	
It
em
	
Essential	 Useful,	but	not	Necessary	 Not	Necessary	or	Redundant	
www.medicaljournals.se/jrm
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ABI (85%) experienced increases in their symptom 
levels related to participation in cognitive assessments, 
with “tired/fatigued” the most frequently endorsed 
symptom. The tool was found to be straight-forward 
to administer by clinicians. Simple modifications 
to instructions based on clinician feedback will be 
incorporated in subsequent iterations to make the 
questionnaire even easier for patients to complete. 
The mean time for completion of the tool was under 
2 min, suggesting that such a tool could easily be 
incorporated into face-to-face or remote assessment/
treatment contexts. 
Based on the initial findings we added further 
questionnaire items, many pertaining to fatigue, as we 
wished to clarify the type(s) of fatigue experienced 
(e.g. mental/physical). The expanded version contai-
ned 40 items. The Lawshe (8) CVR was employed to 
establish the content validity of items. Some definitive 
information for future retention or deletion of items 
was provided by a subset of 23 items, which more than 
half of the consensus panel rated as essential; of those, 
the items “tired/fatigued; trouble staying focused/
concentrating; frustrated; headache; overwhelmed” 
met the highest content validity criterion, with a CVR 
index of > 0.78 (11, 12). 
Further development and scale refinement would 
incorporate iterative CVR ratings, with adherence to 
a structured, anonymous process, such as the Delphi 
method, in which item generation and reduction are 
guided by sources of information such as the CVR. 
While some items showed low CVR and few endor-
sements as “essential” (e.g. worn out, pain, weakness, 
embarrassed), we will consult with an additional expert 
panel to discuss retention of items (or addition of new 
ones) concerning symptoms considered to be rare, but 
of high clinical importance. Also of interest is whether 
the tool can inform clinicians of a threshold that reflects 
“too much” patient burden, which may manifest as a 
total score above the threshold and/or high levels of spe-
cific symptoms. It is interesting that patients who endor-
sed relatively fewer items endorsed predominantly 
physical items, specifically tiredness/fatigue, eye-strain/
blurred vision, and headaches, whereas patients who 
endorsed relatively more items also tended to endorse 
these physical items in addition to greater numbers of 
non-physical items. One hypothesis generated from this 
pattern of item endorsement is that there is an order of 
symptoms that characterizes increasing burden from 
cognitive assessments. For example, burden from a 
neuropsychological assessment may first manifest as 
tiredness, progressing to symptoms of feeling foggy, 
stressed, and overwhelmed. The presence of these lat-
ter symptoms may suggest that a burden threshold has 
been reached; the impact/consequences of reaching the 
threshold would require empirical investigation.
Limitations of the current study include the use 
of a small sample of patients with ABI (precluding 
more rigorous psychometric analysis of the tool), the 
lack of a standardized method for item selection, and 
limited characterization of the patient sample. These 
limitations will be addressed in future stages of de-
velopment, which will include administration of the 
revised questionnaire to a broader cross-section and 
a larger number of patients with ABI. Importantly, 
we will obtain patient input on item addition/reten-
tion and questionnaire instructions through cognitive 
interviews in order to better characterize how patients 
experience burden. 
In conclusion, we have introduced a novel context 
for the measurement of patient treatment burden 
(cognitive assessment/intervention burden in ABI) 
and have taken the first steps in the development of 
a questionnaire for measuring this burden. The tool 
Table II. Lawshe content validity ratio (CVR) values for candidate 
items
Item name CVR value
Anxious 0.4286
Arms/legs feel weak* –0.3846
Bored 0.1429
Cannot think clearly* 0.2308
Confused 0.2857
Desire to close eyes –0.7143
Desire to lay down –0.7143
Distressed –0.2857
Dizzy/lightheaded 0.4286
Distractible 0.4286
Discouraged 0.2857
Ear ringing/popping –0.1429
Embarrassed –0.1429
Eye-strain or blurred vision 0.4286
Foggy 0.2857
Frustrated 0.8571
Head feels heavy –0.4286
Headache 1.0000
Irritable 0.2857
Lonely/isolated –0.4286
Mentally sluggish/slowed down* 0.5385
Muscle aches –0.8571
No energy –0.2857
Off-balance 0.0000
Overwhelmed 1.0000
Pain (other): e.g. neck, arm, hand* 0.5385
Pain/weakness (other)* –0.3846
Racing thoughts –0.1429
Sad 0.5714
Sleepy/drowsy 0.4286
Sore eyes* –0.8462
Stiff shoulders –1.0000
Stressed 0.2857
Tense –0.1429
Tired/fatigued 0.8571
Trouble staying focused/concentrating 1.0000
Uncomfortable –0.2857
Upset 0.1429
Upset/angry 0.0000
Worn out –0.2857
*One rater did not provide a rating for these items; the value reflects an 
adjustment to 13.
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is intended to ultimately help patients, clinicians and 
researchers to recognize burden, and to evaluate how 
burden may impact a patient’s capacity to benefit 
from the assessment or treatment, whether there are 
deleterious psychological or neurological consequen-
ces of burden, and the possible impact of burden on 
subsequent therapeutic and non-therapeutic activities.
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